Insulin Supply Chain is ‘Dysfunctional,’ Claims ADA Official

Drug Industry Daily
A A
Increased transparency in the supply chain is the key to lowering insulin prices, patient advocates and health professional told members of the House Energy and Commerce committee on Tuesday.

To View This Article:

Login

Subscribe To Drug Industry Daily